Cargando…
Antibody Recognition of Cancer Cells via Glycan Surface Engineering
Stimulation of the body's immune system toward tumor cells is now well recognized as a promising strategy in cancer therapy. Just behind cell therapy and monoclonal antibodies, small molecule‐based strategies are receiving growing attention as alternatives to direct immune response against tumo...
Autores principales: | Szponarski, Mathieu, Gademann, Karl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400979/ https://www.ncbi.nlm.nih.gov/pubmed/35638149 http://dx.doi.org/10.1002/cbic.202200125 |
Ejemplares similares
-
In situ recognition of cell-surface glycans and targeted imaging of cancer cells
por: Xu, Xiao-Ding, et al.
Publicado: (2013) -
Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies
por: Wei, Qing, et al.
Publicado: (2020) -
Directing
Neuronal Signaling through Cell-Surface
Glycan Engineering
por: Pulsipher, Abigail, et al.
Publicado: (2014) -
Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies()
por: Le, Ngoc Phuong Lan, et al.
Publicado: (2016) -
NMR Investigation of Protein‐Carbohydrate Interactions: The Recognition of Glycans by Galectins Engineered with Fluorotryptophan Residues
por: Lete, Marta G., et al.
Publicado: (2022)